The genetic duet of concurrent RASAL1 and PTEN alterations forms a unique genetic mechanism that robustly promotes oncogenesis and cancer aggressiveness through cooperatively activating the PI3K pathway, which can be further aggravated by coexisting TP53 alterations. This evidence concerns the gene TP53 and cancer.